Type III Vasa Previa Associated with Resolution of a Low-Lying Placenta: Case Report and Literature Review.

Vasa previa occurs when fetal vessels lie above the cervical os. A novel type of vasa previa, known as type III, is characterized by an abnormal branching of fetal vessels from the placenta in the absence of velamentous cord insertion (as seen in type I) or multilobed placenta (as seen in type II). Here, we present a case of a type III vasa previa after a resolution of a low-lying placenta. The presence of any known risk factors of vasa previa, including low-lying placenta, should prompt screening for vasa previa in the third trimester. Accurate and timely diagnosis of vasa previa will confer significant survival benefit for the neonate.

The fetal scalp electrode shortage is an urgent patient safety issue.

There is currently a shortage of fetal scalp electrodes because of a recent recall due to concerns about the breakage of the electrode tip with possible injury to the neonate. Although the recall is presumably intended to improve safety, the resulting shortage of fetal scalp electrodes poses risks to patients because of inadequate fetal heart rate monitoring in cases where an adequate signal cannot be obtained with external fetal monitoring and/or when maternal heart rate artifact cannot be resolved by repositioning of transducers and application of a maternal pulse oximeter.

Technical Update No. 429: Maternal Heart Rate Artefact During Intrapartum Fetal Health Surveillance.

OBJECTIVE: To improve perinatal outcomes and minimize provider error by increasing awareness of strategies to detect intrapartum maternal heart rate artefact and to respond when such artefact is suspected. TARGET POPULATION: All pregnant patients during labour. OPTIONS: Maternal heart rate artefact may be detected based on clinical features or through technology. Suspected maternal heart rate artefact may be assessed by applying a fetal scalp electrode (preferred) or through external fetal monitoring, augmented by point-of-care sonography (alternative). OUTCOMES: Unrecognized intrapartum maternal heart rate artefact increases the risk that abnormal/atypical fetal heart rate patterns will go undetected and, hence, the risk of adverse perinatal outcomes. BENEFITS, HARMS, AND COSTS: Unrecognized maternal heart rate artefact can lead to adverse perinatal outcomes (hypoxic-ischemic encephalopathy, fetal death, and neonatal death) and adverse maternal outcomes (unnecessary cesarean delivery or operative vaginal delivery). Timely recognition of such artefact may avoid these adverse outcomes. The costs of early recognition of maternal heart rate artefact are relatively small: increased use of fetal scalp electrodes and point-of-care sonography, as well as additional assessments by the health care provider. The cost savings are significant, as a result of lower risk of adverse perinatal outcomes. Potential harms are false-positive diagnoses of maternal heart rate artefact, expediting delivery unnecessarily when the fetal status cannot be reliably determined but is normal, and the rare complications associated with increased use of fetal scalp electrodes. EVIDENCE: Two PubMed searches were completed. The first was for articles published between January 1, 1970, and November 25, 2021, using the medical subject headings (MeSH) "fetal monitoring" and "artifacts" (38 articles). The second was for articles published during the same period using the MeSH "fetal monitoring" and "maternal heart rate" (841 articles). VALIDATION METHODS: The authors rated the quality of evidence and strength of recommendations using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach. See online Appendix A (Tables A1 for definitions and A2 for interpretations of strong and conditional [weak] recommendations). INTENDED AUDIENCE: All health care providers involved in obstetrical care. SUMMARY STATEMENTS: RECOMMENDATIONS.

Mise à jour technique no 429 : Artéfact de la fréquence cardiaque maternelle pendant la surveillance du bien-être fœtal per partum.

OBJECTIF: Améliorer les issues périnatales et réduire au minimum le risque d'erreurs chez les fournisseurs en améliorant leurs connaissances sur les stratégies de détection des artéfacts de la fréquence cardiaque maternelle per partum et sur les modes d'intervention lorsque de tels artéfacts sont soupçonnés. POPULATION CIBLE: Toutes les parturientes. OPTIONS: L'artéfact de la fréquence cardiaque maternelle peut être détecté à l'aide de caractéristiques cliniques ou de la technologie. On peut évaluer l'artéfact de la fréquence cardiaque maternelle soupçonné en posant une électrode de cuir chevelu fœtal (option à privilégier) ou en recourant à la surveillance fœtale externe optimisée par l'échographie au chevet (solution de rechange). RéSULTATS: Les artéfacts de la fréquence cardiaque maternelle per partum non détectés augmentent le risque que des rythmes anormaux ou atypiques de la fréquence cardiaque fœtale passent inaperçus, ce qui augmente le risque d'issues périnatales défavorables. BéNéFICES, RISQUES ET COûTS: L'artéfact de la fréquence cardiaque maternelle non détecté peut entraîner de graves issues périnatales défavorables (encéphalopathie hypoxo-ischémique, mort fœtale et mort néonatale) et des issues maternelles défavorables (césarienne injustifiée ou accouchement assisté). Ces issues peuvent être évitées par la détection rapide d'un tel artéfact. Le coût de la détection précoce des artéfacts de fréquence cardiaque maternelle est relativement faible (utilisation accrue des électrodes de cuir chevelu fœtal et de l'échographie au chevet avec évaluations supplémentaires par le fournisseur de soins). La réduction des événements périnataux défavorables engendre des économies considérables. Les risques sont : faux positifs d'artéfact de la fréquence cardiaque maternelle; accélération inutile de l'accouchement lorsque l'état du fœtus est normal, mais qu'on ne peut le déterminer de façon fiable; et les rares complications associées à l'utilisation accrue des électrodes de cuir chevelu fœtal. DONNéES PROBANTES: Deux recherches ont été effectuées dans PubMed. La première a été réalisée pour répertorier les articles publiés entre le 1er janvier 1970 et le 25 novembre 2021 à partir des termes MeSH fetal monitoring et artifacts (38 articles); la deuxième, pour répertorier les articles publiés au cours de la même période à partir des termes MeSH fetal monitoring et maternal heart rate (841 articles). MéTHODES DE VALIDATION: Les auteurs ont évalué la qualité des données probantes et la force des recommandations en utilisant le cadre méthodologique GRADE (Grading of Recommendations, Assessment, Development, and Evaluation). Voir l'annexe A en ligne (tableau A1 pour les définitions et tableau A2 pour l'interprétation des recommandations fortes et conditionnelles [faibles]). PROFESSIONNELS CONCERNéS: Tous les fournisseurs de soins obstétricaux. DÉCLARATIONS SOMMAIRES: RECOMMANDATIONS.

Mise à jour technique nº 429: Artéfact de la fréquence cardiaque maternelle pendant la surveillance du bien-être fœtal per partum / Technical update mº 429: Maternal heart rate artifact during perpartum fetal health monitoring

Améliorer les issues périnatales et réduire au minimum le risque d'erreurs chez les fournisseurs en améliorant leurs connaissances sur les stratégies de détection des artéfacts de la fréquence cardiaque maternelle per partum et sur les modes d'intervention lorsque de tels artéfacts sont soupçonnés. Population cible Toutes les parturientes. L'artéfact de la fréquence cardiaque maternelle peut être détecté à l'aide de caractéristiques cliniques ou de la technologie. On peut évaluer l'artéfact de la fréquence cardiaque maternelle soupçonné en posant une électrode de cuir chevelu fœtal (option à privilégier) ou en recourant à la surveillance fœtale externe optimisée par l'échographie au chevet (solution de rechange). Les artéfacts de la fréquence cardiaque maternelle per partum non détectés augmentent le risque que des rythmes anormaux ou atypiques de la fréquence cardiaque fœtale passent inaperçus, ce qui augmente le risque d'issues périnatales défavorables. Bénéfices, risques et coûts L'artéfact de la fréquence cardiaque maternelle non détecté peut entraîner de graves issues périnatales défavorables (encéphalopathie hypoxo-ischémique, mort fœtale et mort néonatale) et des issues maternelles défavorables (césarienne injustifiée ou accouchement assisté). Ces issues peuvent être évitées par la détection rapide d'un tel artéfact. Le coût de la détection précoce des artéfacts de fréquence cardiaque maternelle est relativement faible (utilisation accrue des électrodes de cuir chevelu fœtal et de l'échographie au chevet avec évaluations supplémentaires par le fournisseur de soins). La réduction des événements périnataux défavorables engendre des économies considérables. Les risques sont : faux positifs d'artéfact de la fréquence cardiaque maternelle; accélération inutile de l'accouchement lorsque l'état du fœtus est normal, mais qu'on ne peut le déterminer de façon fiable; et les rares complications associées à l'utilisation accrue des électrodes de cuir chevelu fœtal. Deux recherches ont été effectuées dans PubMed. La première a été réalisée pour répertorier les articles publiés entre le 1er janvier 1970 et le 25 novembre 2021 à partir des termes MeSH fetal monitoring et artifacts (38 articles); la deuxième, pour répertorier les articles publiés au cours de la même période à partir des termes MeSH fetal monitoring et maternal heart rate (841 articles). Les auteurs ont évalué la qualité des données probantes et la force des recommandations en utilisant le cadre méthodologique GRADE (Grading of Recommendations, Assessment, Development, and Evaluation). Voir l'annexe A en ligne (tableau A1 pour les définitions et tableau A2 pour l'interprétation des recommandations fortes et conditionnelles [faibles]).

Unrecognized maternal heart rate artefact in cases of perinatal mortality reported to the United States Food and Drug Administration from 2009 to 2019: a critical patient safety issue.

BACKGROUND: Maternal heart rate artefact is a signal processing error whereby the fetal heart rate is masked by the maternal pulse, potentially leading to danger by failure to recognize an abnormal fetal heart rate or a pre-existing fetal death. Maternal heart rate artefact may be exacerbated by autocorrelation algorithms in modern fetal monitors due to smooth transitions between maternal and fetal heart rates rather than breaks in the tracing. In response, manufacturers of cardiotocography monitors recommend verifying fetal life prior to monitoring and have developed safeguards including signal ambiguity detection technologies to simultaneously and continuously monitor the maternal and fetal heart rates. However, these safeguards are not emphasized in current cardiotocography clinical practice guidelines, potentially leading to a patient safety gap. METHODS: The United States Food and Drug Administration Manufacturer and User Facility Device Experience database was reviewed for records with event type "Death" for the time period March 31, 2009 to March 31, 2019, in combination with search terms selected to capture all cases reported involving cardiotocography devices. Records were reviewed to determine whether maternal heart rate artefact was probable and/or whether the report contained a recommendation from the device manufacturer regarding maternal heart rate artefact. RESULTS: Forty-seven cases of perinatal mortality were identified with probable maternal heart rate artefact including 14 with antepartum fetal death prior to initiation of cardiotocography, 14 with intrapartum fetal death or neonatal death after initiation of cardiotocography, and 19 where the temporal relationship between initiation of cardiotocography and death cannot be definitively established from the report. In 29 cases, there was a recommendation from the manufacturer regarding diagnosis and/or management of maternal heart rate artefact. CONCLUSIONS: This case series indicates a recurring problem with undetected maternal heart rate artefact leading to perinatal mortality and, in cases of pre-existing fetal death, healthcare provider confusion. In response, manufacturers frequently recommend safeguards which are found in their device's instructions for use but not in major intrapartum cardiotocography guidelines. Cardiotocography guidelines should be updated to include the latest safeguards against the risks of maternal heart rate artefact. An additional file summarizing key points for clinicians is included.

Prediction of Hypoxic Acidemia in Last 2 Hours of Labour in Low-Risk Women.

OBJECTIVE: Prediction of hypoxic acidemia in neonates using cardiotocogram (CTG) features continues to be challenging. The objective of this study was to explore the association between contraction frequency and fetal heart rate characteristics with hypoxic acidemia in low-risk women in labour. METHODS: Cases were singleton, vertex, in labour with umbilical artery pH ≤7.05. Controls were the next consecutive birth with pH ≥7.15, matched for gestational age, maternal age, and parity. Obstetrical complications and maternal comorbidities were excluded. CTG features were tabulated for the last 2 hours of labour. "Cut-off points" above which acidemia is more likely were calculated for significant variables (Canadian Task Force Classification II-2). RESULTS: A total of 190 case-control pairs were included. Among cases we observed greater marked variability, tachycardia, variable and late decelerations, and fewer accelerations and early decelerations. A conditional logistic regression model included tachycardia, accelerations, total decelerations, and contractions. Tachycardia and total decelerations (variable, late) were significant. Tachycardia was most specific in predicting neonatal acidemia, whereas total (variable, late) decelerations were most sensitive. Late decelerations alone and total (variable, late) decelerations were similarly predictive for detecting neonatal acidemia using receiver-operating characteristic analysis; tachycardia was least discriminatory. Acidemic neonates were more likely to have CTGs with ≥11 late decelerations, ≥15 total decelerations (variable, late), and at least 80 minutes of tachycardia in the last 2 hours of labour. CONCLUSION: Tachycardia, late decelerations, and total (variable, late) decelerations were associated with acidosis in our population. Identifying "cut-off" points for the frequency of significant CTG features should be explored as a potential screening tool for neonatal acidemia.

Delayed clamping of the umbilical cord after delivery and implications for public cord blood banking.

BACKGROUND: Public banking of umbilical cord blood units (CBUs) containing higher numbers of cells ensures timely engraftment after transplantation for increasing numbers of patients. Delayed clamping of the umbilical cord after birth may benefit some infants by preventing iron deficiency. Implications of delayed cord clamping for public cord blood banking remains unclear. STUDY DESIGN AND METHODS: CBUs collected by Canadian Blood Services at one collection site between November 1, 2014, and March 17, 2015, were analyzed. The delay in cord clamping after birth was timed and classified as "no delay," 20 to 60 seconds, more than 60 seconds, or more than 120 seconds. RESULTS: Of 367 collections, 100 reported no delay in clamping while clamping was delayed by 20 to 60 seconds (n = 69), more than 60 seconds (n = 98), or more than 120 seconds (n = 100) in the remaining cases. The mean volume and total nucleated cells (TNCs) in units with no delay in clamping were significantly greater than mean volumes for all categories of delayed clamping (Tukey's test, p < 0.05 for each comparison). The proportion of units with more than 1.5 × 10(9) TNCs was significantly reduced when clamping was delayed (p = 5.5 × 10(-8) ). The difference was most marked for cords that were clamped more than 120 seconds after delivery (6.2% compared with 39%). CONCLUSIONS: Delayed cord clamping greatly diminishes the volume and TNC count of units collected for a public cord blood bank. Creating an inventory of CBUs with high TNC content may take more time than expected.

Shoulder dystocia documentation: an evaluation of a documentation training intervention.

OBJECTIVE: To evaluate the quality and content of nurse and physician shoulder dystocia delivery documentation before and after MORE training in shoulder dystocia management skills and documentation. METHODS: Approximately 384 charts at the Ottawa Hospital General Campus involving a diagnosis of shoulder dystocia between the years of 2000 and 2006 excluding the training year of 2003 were identified. The charts were evaluated for 14 key components derived from a validated instrument. The delivery notes were then scored based on these components by 2 separate investigators who were blinded to delivery note author, date, and patient identification to further quantify delivery record quality. RESULTS: Approximately 346 charts were reviewed for physician and nurse delivery documentation. The average score for physician notes was 6 (maximum possible score of 14) both before and after the training intervention. The nurses' average score was 5 before and after the training intervention. CONCLUSIONS: Negligible improvement was observed in the content and quality of shoulder dystocia documentation before and after nurse and physician training.

The importance of a late first trimester placental sonogram in patients at risk of abnormal placentation.

Background. Placenta accreta is a potentially life-threatening obstetrical condition and is responsible for many emergency Caesarean hysterectomies. Early prenatal diagnosis may help minimize maternal morbidity and mortality. This report highlights risk factors, early diagnostic findings and complications associated with placenta accreta, and the role of first trimester sonography in diagnosis. Case. A 38-year-old pregnant woman, G2P1L1 with history of one previous Caesarean section, presented with vaginal bleeding at 13 weeks' gestation. Ultrasound examination was highly suspicious of placenta previa with accreta. During an earlier 12-week scan for nuchal translucency measurement, the placenta was suboptimally visualized. She was counselled regarding potential maternal and fetal complications as well as management options. At 33 weeks' gestation Caesarean hysterectomy was performed due to vaginal bleeding. Conclusion. Early ultrasound screening in high-risk patients may be advantageous in order to identify placenta accreta and conduct appropriate patient counseling regarding risks and management options.

The incidence of maternal artefact during intrapartum fetal heart rate monitoring.

OBJECTIVE: To determine the incidence of maternal heart rate artefact (MHRA) when monitoring fetal heart rate (FHR) in labour and to determine obstetrical factors associated with MHRA. METHODS: In a prospective observational study, maternal and fetal heart rates were displayed simultaneously to document the superimposition of the maternal heart rate (MHR) on FHR tracings. All women in labour who were undergoing external fetal monitoring (EFM) at the Ottawa Hospital from October 2011 to March 2012 were eligible. Every episode of MHRA was documented and classified according to its clinical significance. Wilcoxon test, t tests, and chi-square tests were used to identify time-related differences and obstetrical factors (epidural analgesia, fetal presentation, multiple gestation, maternal BMI, umbilical cord arterial pH, five-minute Apgar scores) that were associated with a potential adverse outcome. RESULTS: We assessed 1313 tracings with simultaneous displays of the MHR and FHR in labour. MHRA was present at least once in 721 tracings (55%). Of these tracings, 35 were classified as having one or more episodes that might have led to an adverse outcome (either false positive or false negative), giving an incidence of 2.7% of all women in labour. In 33 tracings, the MHRA masked an abnormal FHR tracing. In two tracings, the MHRA masked a normal FHR, which might have resulted in misinterpretation of the tracing (i.e., false positive), leading to unnecessary intervention. CONCLUSION: The incidence of MHRA is higher than currently thought, and in more than 2% of women in labour may lead to adverse outcomes. We propose routine use of simultaneous maternal and FHR monitoring for women undergoing EFM, especially during the second stage of labour.

Objectif : Déterminer l'incidence des artéfacts de fréquence cardiaque maternelle (AFCM) dans le cadre du monitorage de la fréquence cardiaque fœtale (FCF) pendant le travail et identifier les facteurs obstétricaux associés aux AFCM. Méthodes : Dans le cadre d'une étude observationnelle prospective, les fréquences cardiaques maternelles et fœtales ont été affichées de façon simultanée afin de documenter la superposition de la fréquence cardiaque maternelle (FCM) sur les tracés de FCF. Toutes les femmes en travail qui, entre octobre 2011 et mars 2012, ont fait l'objet d'un monitorage fœtal externe (MFE) à l'Hôpital d'Ottawa étaient admissibles à l'étude. Chaque épisode d'AFCM a été documenté et classé en fonction de sa signification clinique. Le test de Wilcoxon, des tests t et des tests de chi carré ont été utilisés pour identifier les différences liées au temps et les facteurs obstétricaux (analgésie péridurale, présentation fœtale, gestation multiple, IMC maternel, pH du sang artériel issu du cordon ombilical, indices d'Apgar à cinq minutes) qui ont été associés à une issue indésirable potentielle. Résultats : Nous avons évalué 1 313 tracés ayant affiché de façon simultanée la FCM et la FCF pendant le travail. Des AFCM ont été présents à au moins une reprise dans 721 tracés (55 %). Parmi ces tracés, 35 ont été classés comme présentant un épisode ou plus qui aurait pu mener à une issue indésirable (faux positif ou faux négatif), ce qui équivaut à une incidence de 2,7 % de toutes les femmes en travail. Dans 33 tracés, les AFCM ont masqué un tracé anormal de FCF. Dans deux tracés, les AFCM ont masqué un tracé normal de FCF, ce qui aurait pu mener à une interprétation erronée du tracé (c.-à-d. faux positif) et à la mise en œuvre d'une intervention inutile. Conclusion : L'incidence des AFCM est supérieure aux estimations actuelles; chez plus de 2 % des femmes en travail, ils pourraient mener à des issues indésirables. Nous proposons l'utilisation systématique du monitorage simultané de la FCM et de la FCF pour ce qui est des femmes faisant l'objet d'un MFE, particulièrement au cours du deuxième stade du travail.

A multidisciplinary checklist for management of suspected placenta accreta.

Rates of abnormally invasive placentation have been escalating. The condition requires meticulous planning to ensure safety at delivery. Although placenta accreta remains the most common reason for Caesarean hysterectomy in developed nations, medical and surgical therapies have allowed fertility preservation. Most planning strategies start with risk factor assessment and diagnostic imaging. Early planning of arrangements for antepartum and intrapartum management is preferable to late planning, when emergency situations are more likely to occur. Based on maternal and fetal morbidities, and published evidence of factors that may diminish these risks, we have developed a checklist to aid the antepartum and intrapartum management of potentially challenging cases of invasive placentation or to aid in considering tertiary care consultation and transfer. The proposed checklist may best benefit physicians working in primary and secondary levels of care in Canada. Ideally, this checklist would be available in electronic form, with alerts as needed; a copy of the checklist should be kept in the patient's medical chart, with periodic updates.

Application of 3-d angiography in the management of placenta percreta treated with repeat uterine artery embolization.

BACKGROUND: Rising Caesarean section rates have increased rates of abnormally invasive placentation. In the management of such invasive placentation, hysterectomy may result in greater morbidity than more conservative measures. Non-surgical interventions such as uterine artery embolization (UAE) attempt to decrease placental perfusion and augment placental resorption. Repeat UAE may decrease the risk of unpredictable hemorrhage requiring emergency intervention. Three-dimensional angiography is a novel technology for assessing volume with objective measures of internal flow. CASE: We report a case of placenta previa percreta that was treated conservatively by repeat UAE for persistent densely perfused placenta. Three-dimensional angiography was used to objectively assess placental characterization and vascularization. CONCLUSION: Repeat UAE may be beneficial in reducing the risk of delayed hemorrhage in women with placenta previa accreta or percreta managed conservatively. Objective assessment of placental volume and vascularity by 3-D angiography can provide data on patients at risk and allow case selection for repeat UAE.

The Ottawa hospital quality incident notification system for capturing adverse events in obstetrics.

OBJECTIVE: To describe the design and implementation of a Quality Incident Notification (QIN) system in an obstetrical unit and provide an analysis of the frequency and nature of events captured by the system. METHODS: We implemented a system to capture quality events, consisting of an on-line form that was easily accessible to all levels of staff. A list of quality indicators was developed to indicate potential safety concerns, near misses, or poor outcomes that required closer scrutiny. We retrospectively analyzed the cases reported in the first year following introduction of the QIN for the presence, severity, and avoidability of harm. RESULTS: During the 12-month study period there were 6752 deliveries, and 578 QINs were generated, a rate of one QIN for every 11.7 deliveries (8.5%). The most frequent indicators reported were "neonatal near miss" (15.4%), "records/results" (14.5%), and "staff communication" (10.0%). Out of the 497 QINs with complete data, 67 (13.4%) showed minor harm to the mother, the baby, or both, and 37 (7.4%) QINs showed major harm. Only 28 of the 110 cases of actual harm were considered to be caused by the medical care (0.4% of all deliveries), and 14 patients were judged to have experienced avoidable actual harm due to medical care (0.2% of all deliveries). CONCLUSION: The QIN system captured a relatively low rate of adverse events, with about half of these being avoidable. Used consistently, this type of system can be an effective tool for risk management and improvement of practices.

A teaching encounter card to evaluate clinical supervisors across clerkship rotations.

BACKGROUND: Evaluation of faculty teaching is critical to improving the educational experience for both students and faculty. AIM: Our objectives were to implement an evaluation system, using the teaching encounter card, across multiple rotations in the clerkship and determine the feasibility, reliability and validity of this evaluation tool in this expanded setting. METHODS: Students were asked to rate clinical supervisors on nine teaching behaviours using a 6-point rating scale and asked whether they would like to nominate the teacher for a clinical teaching award. RESULTS: A total of 3971 cards for 587 clinical supervisors across seven clerkship rotations were analyzed. There was an average of 7.3 cards per supervisor (median = 5, range 2-66). There was high internal consistency between items on the card (Cronbach's alpha 0.965). The reliability was fair at 0.63. Seventeen cards per supervisor would be required to achieve a reliability >0.8 (G study). Ratings were higher for encounters that occurred in the operating room and within the anaesthesia rotation. The teachers who had a positive recommendation for teaching award nomination received higher scores than their colleagues. CONCLUSION: We successfully implemented a faculty evaluation card across clerkship rotations that was flexible enough to use in multiple learning environments and allowed the identification of outstanding clinical teachers.

Comparison of maternal risk factors between placental abruption and placenta previa.

The purpose of this study was to compare risk factors between placental abruption and placenta previa among primiparous and multiparous singleton pregnancies. We analyzed data from a population-based retrospective cohort with singleton pregnancies in the United States for 1995 to 2000. Maternal risk factors for placenta previa and placental abruption were examined using multiple logistic regressions. A total of 5,630,854 primiparous and 11,026,768 multiparous singleton pregnancies were available for final analyses after excluding subjects with missing information on outcomes or important exposures. Placental abruption was recorded in 4.8 per 1000 primiparous singleton births and 5.9 per 1000 multiparous singleton pregnancies. The occurrence of placenta previa was 1.9 per 1000 primiparous singleton pregnancies and 3.9 per 1000 multiparous singleton pregnancies. The effects of maternal age, race, parity, and previous cesarean section were stronger on placenta previa than on placental abruption, and the effects of cigarette smoking, alcohol drinking, and prenatal care were stronger on placental abruption than on placenta previa. A composite outcome of selected medical and pregnancy complications was related with placental abruption but not with placental previa. Placental abruption is more likely to be affected by conditions occurring during pregnancy, and placenta previa is more likely to be affected by conditions existing prior to pregnancy.

Compliance of medical students with voluntary use of personal data assistants for clerkship assessments.

BACKGROUND: For several years, final-year students at McMaster University have been required to complete 10 mini-CEX type assessments per rotation. A similar system was being introduced at Ottawa. PURPOSE: To facilitate data capture, we decided to introduce a personal data assistant (PDA)-based system and evaluate its impact. METHOD: A randomized trial was designed to compare the acceptability of PDA and printed evaluation forms. The trial failed because of clerks' unwillingness to use PDAs. A focus group was held and user surveys were administered, chiefly by e-mail, to explore students' preference for printed forms. RESULTS: Thirty percent of invited clerks (52/176) agreed to use a PDA; 6% (11; 21% of those agreeing) recorded one or more encounters; 2% (4) recorded at least the minimum number of evaluations required by their program. Most survey respondents expressed concerns related primarily to the relative inconvenience of PDAs compared to paper, a judgment reflecting the time required both to install required software and to become familiar with the software and data entry form, and to record information via the form. A minority were also concerned about assessors' willingness or ability to use PDA forms. CONCLUSION: Before asking students and clinical supervisors to use a PDA-based encounter-evaluation form in clerkship, planners should conduct a careful assessment of the advantages and disadvantages for students of the system they hope to implement. The prima facie greater convenience and efficiency of the PDA may actually be offset by workplace disincentives and inefficiencies in data recording, relative to the incentives and efficiencies associated with a system based on printed (paper) forms.

Knowledge to action: implementing a guideline for second stage labor.

PURPOSE: To quantify practice changes associated with implementing a clinical practice guideline for the second stage of labor in term nulliparous women with epidural anesthesia and to describe the lessons learned about knowledge translation. The main clinical practice guideline recommendation was waiting up to 2 hours before pushing after full dilatation. DESIGN AND METHODS: Pre- and post-evaluation of clinical outcomes and knowledge translation strategies associated with implementing the second stage of labor clinical practice guideline at two birthing units within a large teaching hospital. RESULTS: The implementation of the clinical practice guideline resulted in a significant increase in median waiting time before pushing of 33 minutes at Site 1. This change was also reflected in the twofold increase in the proportion of women waiting longer than 120 minutes before pushing at this site. There was no change in waiting time at Site 2. The duration of the second stage did not change significantly at either site. The median pushing time decreased at both sites but was only statistically significant at Site 1. CLINICAL IMPLICATIONS: Bringing about practice change in obstetrics is complex. The measured change in this study was less than we expected. Greater success might have been achieved by enhancing feedback to care providers and more frequent audits of practice. We need to better understand the subtle influences in attitude and culture that prevented successful implementation in one site. For units considering a similar process, we recommend a commensurately greater level of presence in the units to encourage compliance with the clinical practice guideline in order to achieve the desired level of practice change.